Molecular therapy for Metastatic human tumors: Ndfip1 inhibits cellular proliferation, invasion and metastasis by increasing the expression of metastasis suppressor BTG2 via down regulation of its target gene, 2/May/2015, 6.45 am

MiRNA-based Exercise-Mimicking pills may inhibit Insulin resistance and decrease adiposity: MiRNA-1269 decreases gluconeogenesis genes, such as PEPCK and G6Pase, reduces hepatic glucose production, improves muscle insulin sensivitity and decreases adiposity via up regulation of its target gene, 2/May/2015, 6.36 am
May 2, 2015
Small molecule-based Lifespan extension therapy: PDGF-B inhibits senescence and extends life span by down regulating the expression of adenylate cyclase 5 (ADCY5), 2/May/2015, 07.08 am
May 2, 2015
Show all

A study from the Cell Pathology Division, The Children’s Hospital of Philadelphia, Philadelphia, USA shows that “TGF-β induces the expression of the adaptor Ndfip1 to silence IL-4 production during iTreg cell differentiation.” This study was published in the 15 November  2009 issue of the journal “Nature Immunology” [the number 1 journal in Immunology with an I.F of 24.973] by Prof. Oliver PM, Beal and Others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular therapy for Metastatic human tumors: Ndfip1 inhibits cellular proliferation, invasion and metastasis by increasing the expression of metastasis suppressor BTG2  via down regulation of its target gene. 

Significance: This study suggests, for the first time, that adoptor Ndfip1, by decreasing the expression of its target gene, it may increase the expression of BTG2Thus, pharmacological formulations encompassing “Ndfip1 activators” may be used to stall metastatic progression. 

Undisclosed information: How Ndfip1 increases the expression of BTG2 

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular therapy for Metastatic human tumors: Ndfip1 inhibits cellular proliferation, invasion and metastasis by increasing the expression of metastasis suppressor BTG2 via down regulation of its target gene, 2/May/2015,  6.45 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Comments are closed.